A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2006
12/28/2006	US20060292072 Agents for neutron capture therapy
12/28/2006	CA2623215A1 Assay for vitamin b12 absorption and method of making labeled vitamin b12
12/27/2006	EP1736163A1 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
12/27/2006	EP1735432A1 Cancerous disease modifying antibodies
12/27/2006	EP1735013A2 Alpha-emitting hydroxyapatite particles
12/27/2006	EP1735012A2 Targeting of radioimagining and radiotherapy agents
12/27/2006	EP1734997A2 Steroid sparing agents and methods of using same
12/27/2006	EP1381604B1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
12/27/2006	CN1886151A Pharmaceutical formulations for the sustained release of oneor more active principles and applications thereof, such as therapeutic applications
12/26/2006	US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
12/26/2006	US7153506 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family
12/21/2006	WO2006135374A2 Rubidium-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets
12/21/2006	WO2006135270A1 Method for carrying out a magnetic therapy of malignant neoplasms
12/21/2006	WO2006134822A1 Radioactive diagnostic imaging agent
12/21/2006	WO2006088476A3 Carboranylporphyrins and uses thereof
12/21/2006	WO2006050420A3 Chimeric immunogens that comprise ovalbumin
12/21/2006	WO2006023882A3 Anti-perspirant compositions with improved properties
12/21/2006	WO2005120586A3 Copolymers comprising positively and negatively charged aminoacids conjugated to chelants
12/21/2006	WO2004063332A3 Cancer related genes
12/21/2006	US20060287220 Water soluble paclitaxel prodrugs
12/21/2006	US20060286033 Targeting pulmonary epithelium using ADRP
12/21/2006	US20060286032 A radiosotope-chitosan complex for treatment of prostate cancer
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	US20060286030 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells
12/21/2006	US20060285623 Methods and apparatus for producing 15O-carbon monoxide and 15O-carbon dioxide
12/21/2006	CA2610252A1 Radioactive diagnostic imaging agent
12/20/2006	EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006	EP1733745A2 Radioactively coated devices
12/20/2006	EP1732864A1 Radiolabeled 3-¬3- (benzoyl-amido) benzyloxy\| aspartic acid derivative and method of producing the same
12/20/2006	EP1732608A2 Folate conjugates and complexes
12/20/2006	EP1732603A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
12/20/2006	EP1732602A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
12/20/2006	EP1147111B1 Cryptate compounds and methods for diagnosis and therapy
12/20/2006	CN1882365A Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
12/20/2006	CN1882364A Contrast agent for medical imaging techniques and usage thereof
12/20/2006	CN1290849C Compound of benzopyran category marked by fluorin [*F] as well as preparation method and its application of developing agent for D4 receptor of dopamine
12/19/2006	US7151162 Capable of interacting with wnt-signalling pathway (beta-catenins and T-cell factors); cancer diagnosis
12/19/2006	US7150888 Methods and apparatus to prevent colds, influenzaes, tuberculosis and opportunistic infections of the human respiratory system
12/19/2006	US7150867 Radionuclide-coated particulate material
12/14/2006	WO2006132388A1 Bone marrow-directing drug delivery materials and their applications
12/14/2006	WO2005099775A3 Labeled anwexin for predicting the response to a therapeutic regimen
12/14/2006	US20060281776 Isotope labeled camptothecin derivatives
12/14/2006	US20060281072 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy
12/14/2006	US20060280680 Hybrid nanocrystals for treatment and bioimaging of disease
12/14/2006	US20060280679 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
12/13/2006	EP1729824A2 Phospholipid analogs for diagnosis and treatment of cancer
12/13/2006	EP1729823A2 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
12/13/2006	EP1729822A1 Particulate materials and compositions for radio therapy
12/13/2006	EP1729821A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins
12/13/2006	EP1729820A2 Perturbed membrane-binding compounds and methods of using the same
12/13/2006	EP1729815A2 Pegylated ion channel modulating compounds
12/13/2006	EP1729814A2 Pegylated ion channel modulating compounds
12/13/2006	EP1599882B1 Method for producing actinium-225
12/13/2006	EP1392676B1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
12/13/2006	EP1390549B1 Metal-zirconia composite coating
12/13/2006	CN1878562A Antybody therapy
12/12/2006	US7148190 Haptotactic peprides
12/12/2006	US7147856 Stable radioiodine conjugates and methods of their synthesis
12/12/2006	US7147838 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases
12/12/2006	US7147837 Bioactivated diagnostic imaging constrast agents
12/07/2006	WO2006128951A1 Compositions for targeting amine oxidases in vivo
12/07/2006	WO2006081418A3 Ephb receptor-binding peptides
12/07/2006	WO2005048822A3 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
12/07/2006	US20060275308 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
12/07/2006	US20060275215 Novel imaging agents
12/07/2006	US20060275214 Methods of screening for anti-inflammatory drugs and use thereof
12/07/2006	US20060275213 Tumor targeting agents and uses thereof
12/07/2006	US20060275212 Treatment and diagnosis of cancer
12/07/2006	US20060275211 Antibodies and related molecules that bind to 161P2F10B proteins
12/07/2006	US20060275210 inhibit proliferation of CK-B4 expression; used to diagnose, treat, prevent cancer, to inhibit the progression or metastasis of myeloproliferative and other disorders such as leukemia, T-cell lymphoma, and/or B-cell lymphoma
12/07/2006	US20060275209 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds
12/07/2006	US20060275208 Miniaturized 62zn/62cu generator for high concentration clinical delivery of 62cu kit formulation for the facile preparation of radiolabeled cu-bis(thiosemicarbazone)compounds
12/06/2006	EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
12/06/2006	EP1728520A1 Use of radiopharmaceutical compounds which are specific binders to serotonine transporters for the preparation of a diagnotic agent for the examination of headache related disorders
12/06/2006	EP1728518A1 Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
12/06/2006	EP1631320B1 Use of a tetrapeptide acsdkp analogue resistant to the angiotensin i conversion enzyme, for measuring glomerular filtration rate in a human or an animal and kit containing same
12/06/2006	EP1631146A4 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/06/2006	EP1423526B1 An enzymatic process for the synthesis of organo-fluorine compounds
12/06/2006	CN1287859C Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
12/05/2006	US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
12/05/2006	CA2277180C Method to enhance tissue accumulation of radiolabeled compounds
11/2006
11/30/2006	WO2006127024A1 Reagents and methods for labeling terminal olefins
11/30/2006	WO2006126410A1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
11/30/2006	US20060269511 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
11/30/2006	US20060269481 Using cancerous disease modifying antibodies, optionally in combination with one or more chemotherapeutic agents,against the target antigen; improved prognoses; receptor binding assays
11/30/2006	US20060269480 Multi-triggered self-immolative dendritic compounds
11/30/2006	US20060269479 Amphiphilic polymers and methods of use thereof
11/30/2006	US20060269478 Use of protein occlusion for the selective delivery of small molecules to targets
11/30/2006	US20060269477 ST receptor binding compounds and methods of using the same
11/30/2006	US20060269476 Method for integrating large scale biological data with imaging
11/30/2006	US20060269475 Multi-layer structure having a predetermined layer pattern including an agent
11/30/2006	US20060269474 radiolabeled compounds such as (4-(2-(4-(2-(2-(2-(2-(2-(2-(2-(2-Fluoro-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-phenyl)-vinyl)-phenyl)-methyl-amine, used for quantitating amyloid deposits
11/30/2006	US20060269473 radiolabeled compounds such as [4-(2-{4-[2-(2-Fluoro-ethoxy)-ethoxy]-phenyl}-vinyl)-phenyl]-methyl-amine, used for the detection of amyloid proteins deposits; medical diagnosis
11/30/2006	DE10137566B4 Verfahren zur Quantifizierung der Austauschprozesse in den Atemwegen A method for quantifying the exchange processes in the airways
11/29/2006	EP1725589A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
11/29/2006	EP1725269A1 Catalytic radiofluorination
11/29/2006	EP1239886B1 Labelled ascorbic acid derivatives
11/29/2006	CN1871233A Novel chelating agents and chelates and their use
11/28/2006	US7141234 Imaging of drug accumulation as a guide to antitumor therapy
11/28/2006	US7141233 Radionuclide labeling of vitamin B12 and coenzymes thereof

1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 243